Biocoral, Inc.

Japanese patent approved for method for inducing osteoblast differentiation

Published in Medical Verdicts and Law Weekly, July 28th, 2005

Biocoral, Inc., (BCRA) announced that recently the Japanese Patent Office (JPO) approved and granted a company patent called method for inducing osteoblast differentiation of human extramedullary adipose tissue cells "Coral block - bone cells".

The Japanese Patent Office, after almost 7 years of examining of the company's application, granted the patent innovation to Bio Holdings International, Ltd., the company's wholly owned subsidiary, under the patent number 3650734. The patent will expire in 2018.

The JPO is officially part of the Ministry of Economy, Trade and Industry in Japan (METI) and contributes to the development of industry by securing...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly

Source: Medical Verdicts and Law Weekly (2005-07-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry